These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22207318)

  • 1. Evolution of postmenopausal hormone therapy between 2002 and 2009.
    Ettinger B; Wang SM; Leslie RS; Patel BV; Boulware MJ; Mann ME; McBride M
    Menopause; 2012 Jun; 19(6):610-5. PubMed ID: 22207318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of postmenopausal hormone therapy between 2002 and 2009.
    Ettinger B; Wang SM; Leslie RS; Patel BV; Boulware MJ; Mann ME; McBride M
    Menopause; 2018 Nov; 25(11):1306-1312. PubMed ID: 30358727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative.
    Steinkellner AR; Denison SE; Eldridge SL; Lenzi LL; Chen W; Bowlin SJ
    Menopause; 2012 Jun; 19(6):616-21. PubMed ID: 22648302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal health interventions: Time to move on from the Women's Health Initiative?
    Thaung Zaw JJ; Howe PRC; Wong RHX
    Ageing Res Rev; 2018 Dec; 48():79-86. PubMed ID: 30355506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Women's Health Initiative: an unforgettable decade.
    Pal L; Manson JE
    Menopause; 2012 Jun; 19(6):597-9. PubMed ID: 22648299
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.
    Shufelt CL; Merz CN; Prentice RL; Pettinger MB; Rossouw JE; Aroda VR; Kaunitz AM; Lakshminarayan K; Martin LW; Phillips LS; Manson JE
    Menopause; 2014 Mar; 21(3):260-6. PubMed ID: 24045672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in oral and vaginally administered estrogen use among US women 50 years of age or older with commercial health insurance.
    Weissfeld JL; Liu W; Woods C; Zhang R; Li J; van der Vlugt TH; Slaughter SR
    Menopause; 2018 Jun; 25(6):611-614. PubMed ID: 29286985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
    Carroll N
    J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy prescribing trends in the decade after the Women's Health Initiative: how patients and providers have found a way to sleep better at night.
    Corbelli JA; Hess R
    Menopause; 2012 Jun; 19(6):600-1. PubMed ID: 22648300
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone replacement therapy prescription: a disconnect between personal and patient prescribing.
    Fenton A; Panay N
    Climacteric; 2012 Oct; 15(5):409-10. PubMed ID: 22978256
    [No Abstract]   [Full Text] [Related]  

  • 14. The Women's Health Initiative - a decade of progress.
    Fenton A; Panay N
    Climacteric; 2012 Jun; 15(3):205. PubMed ID: 22612604
    [No Abstract]   [Full Text] [Related]  

  • 15. Transdermal estrogens in the changing landscape of hormone replacement therapy.
    Beck KL; Anderson MC; Kirk JK
    Postgrad Med; 2017 Aug; 129(6):632-636. PubMed ID: 28540770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.
    Crawford SL; Crandall CJ; Derby CA; El Khoudary SR; Waetjen LE; Fischer M; Joffe H
    Menopause; 2018 Dec; 26(6):588-597. PubMed ID: 30586004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy.
    Simon JA; Laliberté F; Duh MS; Pilon D; Kahler KH; Nyirady J; Davis PJ; Lefebvre P
    Menopause; 2016 Jun; 23(6):600-10. PubMed ID: 26953655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decade after the Women's Health Initiative--the experts do agree.
    Stuenkel CA; Gass ML; Manson JE; Lobo RA; Pal L; Rebar RW; Hall JE
    Menopause; 2012 Aug; 19(8):846-7. PubMed ID: 22776849
    [No Abstract]   [Full Text] [Related]  

  • 19. A decade after the Women's Health Initiative--the experts do agree.
    Stuenkel CA; Gass ML; Manson JE; Lobo RA; Pal L; Rebar RW; Hall JE
    Fertil Steril; 2012 Aug; 98(2):313-4. PubMed ID: 22784968
    [No Abstract]   [Full Text] [Related]  

  • 20. What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?
    Simon JA
    Menopause; 2014 Jul; 21(7):769-83. PubMed ID: 24398406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.